tiprankstipranks
Trending News
More News >
Cannara Biotech (TSE:LOVE)
:LOVE
Canadian Market

Cannara Biotech (LOVE) Ratios

Compare
37 Followers

Cannara Biotech Ratios

TSE:LOVE's free cash flow for Q4 2025 was C$―. For the 2025 fiscal year, TSE:LOVE's free cash flow was decreased by C$ and operating cash flow was C$―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 25Dec 24Dec 23
Liquidity Ratios
Current Ratio
2.43- 2.50 2.44 3.46
Quick Ratio
1.01- 1.01 0.85 1.86
Cash Ratio
0.42- 0.25 0.20 1.02
Solvency Ratio
0.30- 0.19 0.19 0.11
Operating Cash Flow Ratio
0.56- 0.40 0.26 -0.51
Short-Term Operating Cash Flow Coverage
1.50- 1.16 0.91 -3.09
Net Current Asset Value
C$ 12.51M-C$ 705.36KC$ -10.08MC$ -17.89M
Leverage Ratios
Debt-to-Assets Ratio
0.28- 0.31 0.32 0.39
Debt-to-Equity Ratio
0.48- 0.55 0.57 0.73
Debt-to-Capital Ratio
0.32- 0.35 0.36 0.42
Long-Term Debt-to-Capital Ratio
0.26- 0.30 0.33 0.41
Financial Leverage Ratio
1.73- 1.76 1.77 1.88
Debt Service Coverage Ratio
1.41- 1.15 1.40 2.60
Interest Coverage Ratio
4.70- 1.78 2.24 1.91
Debt to Market Cap
0.31- 0.78 0.51 0.41
Interest Debt Per Share
0.57- 0.60 0.57 0.57
Net Debt to EBITDA
1.23- 2.75 2.63 3.80
Profitability Margins
Gross Profit Margin
44.57%-36.44%47.56%48.36%
EBIT Margin
20.23%-10.78%18.91%12.49%
EBITDA Margin
26.33%-18.55%27.54%26.62%
Operating Profit Margin
21.48%-12.33%20.76%10.25%
Pretax Profit Margin
17.01%-5.49%12.13%6.43%
Net Profit Margin
15.21%-7.88%12.13%6.43%
Continuous Operations Profit Margin
15.21%-7.88%12.13%6.43%
Net Income Per EBT
89.41%-143.59%100.00%100.00%
EBT Per EBIT
79.18%-44.49%58.42%62.78%
Return on Assets (ROA)
9.12%-4.16%4.91%1.84%
Return on Equity (ROE)
16.72%-7.32%8.71%3.45%
Return on Capital Employed (ROCE)
16.18%-7.89%9.88%3.23%
Return on Invested Capital (ROIC)
13.17%-10.55%9.41%3.92%
Return on Tangible Assets
9.12%-4.16%4.91%1.84%
Earnings Yield
9.81%-10.51%7.78%1.95%
Efficiency Ratios
Receivables Turnover
7.24- 6.27 5.41 4.16
Payables Turnover
4.60- 26.45 3.38 2.17
Inventory Turnover
1.15- 1.30 0.89 0.98
Fixed Asset Turnover
1.19- 0.96 0.64 0.43
Asset Turnover
0.60- 0.53 0.40 0.29
Working Capital Turnover Ratio
2.20- 2.30 1.92 1.73
Cash Conversion Cycle
287.32- 325.90 370.01 293.73
Days of Sales Outstanding
50.40- 58.21 67.52 87.76
Days of Inventory Outstanding
316.18- 281.49 410.49 374.25
Days of Payables Outstanding
79.26- 13.80 108.00 168.28
Operating Cycle
366.58- 339.70 478.01 462.01
Cash Flow Ratios
Operating Cash Flow Per Share
0.21- 0.12 0.06 -0.07
Free Cash Flow Per Share
0.15- 0.04 -0.05 -0.25
CapEx Per Share
0.06- 0.08 0.11 0.18
Free Cash Flow to Operating Cash Flow
0.72- 0.30 -0.82 3.54
Dividend Paid and CapEx Coverage Ratio
3.63- 1.43 0.55 -0.39
Capital Expenditure Coverage Ratio
3.63- 1.43 0.55 -0.39
Operating Cash Flow Coverage Ratio
0.41- 0.22 0.12 -0.13
Operating Cash Flow to Sales Ratio
0.19- 0.13 0.09 -0.17
Free Cash Flow Yield
8.97%-5.25%-4.97%-18.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
9.90- 9.51 12.86 51.34
Price-to-Sales (P/S) Ratio
1.50- 0.75 1.56 3.30
Price-to-Book (P/B) Ratio
1.56- 0.70 1.12 1.77
Price-to-Free Cash Flow (P/FCF) Ratio
10.78- 19.06 -20.10 -5.49
Price-to-Operating Cash Flow Ratio
7.86- 5.73 16.42 -19.47
Price-to-Earnings Growth (PEG) Ratio
0.74- -1.17 0.07 -0.31
Price-to-Fair Value
1.56- 0.70 1.12 1.77
Enterprise Value Multiple
6.91- 6.79 8.29 16.21
Enterprise Value
190.82M- 102.95M 130.81M 154.63M
EV to EBITDA
7.10- 6.79 8.29 16.21
EV to Sales
1.87- 1.26 2.28 4.31
EV to Free Cash Flow
13.48- 32.03 -29.45 -7.18
EV to Operating Cash Flow
9.77- 9.64 24.06 -25.44
Tangible Book Value Per Share
1.08- 0.98 0.89 0.76
Shareholders’ Equity Per Share
1.08- 0.98 0.89 0.76
Tax and Other Ratios
Effective Tax Rate
0.11- -0.44 0.00 -0.24
Revenue Per Share
1.12- 0.91 0.64 0.41
Net Income Per Share
0.17- 0.07 0.08 0.03
Tax Burden
0.89- 1.44 1.00 1.00
Interest Burden
0.84- 0.51 0.64 0.51
Research & Development to Revenue
<0.01- 0.01 0.02 0.04
SG&A to Revenue
0.12- 0.16 0.19 0.24
Stock-Based Compensation to Revenue
<0.01- 0.02 0.03 <0.01
Income Quality
1.26- 1.66 0.78 -2.64
Currency in CAD